Arecor Therapeutics (LON:AREC) Stock Price Down 5.5% – Here’s What Happened

Shares of Arecor Therapeutics plc (LON:AREC) traded down 5.5% during mid-day trading on Tuesday . The company traded as low as GBX 73.22 and last traded at GBX 73.22. 27,662 shares changed hands during mid-day trading, an increase of 29% from the average session volume of 21,410 shares. The stock had previously closed at GBX 77.50.

Arecor Therapeutics Stock Performance

The firm has a market capitalization of £27.65 million, a price-to-earnings ratio of -3.18 and a beta of -0.18. The firm’s 50-day moving average price is GBX 82.10 and its two-hundred day moving average price is GBX 74.91. The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37.

About Arecor Therapeutics

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.